NANTES, France, November 7, 2025 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage biotechnology company developing immunotherapies for cancer and autoimmune ...

The global oncology market is rapidly shifting toward smarter drug-delivery systems that enhance efficacy, reduce toxicity ...

As of Friday, November 07, CytomX Therapeutics, Inc.’s CTMX share price has dipped by 18.38%, which has investors questioning ...

Company announces U.S. FDA clearance of Investigational New Drug (IND) application for STRO-004, its potential best-in-class Tissue Factor ADC; ...

The global cancer-therapy landscape is undergoing a rapid evolution toward precision drug-delivery systems designed to boost efficacy, ...

NetworkNewsWire Editorial Coverage NEW YORK, Oct. 29, 2025 /PRNewswire/ -- The global cancer-therapy landscape is undergoing a rapid evolution toward ...

NetworkNewsWire Editorial Coverage NEW YORK, Oct. 27, 2025 /PRNewswire/ -- The global oncology market is rapidly shifting toward smarter drug-delivery ...

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability In Oncology - Financial News Media. NetworkNewsWire Editorial Coverage New York, NY – October 27, 2025 – The global ...

Nanomedicine Innovations Transforming Oncology Drug Delivery And Bioavailability - Financial News Media. NetworkNewsWire Editorial Coverage New York, NY – October 29, 2025 – The global cancer-therapy ...

Subcutaneous injections of an investigational, selective long-acting amylin receptor agonist led to clinically meaningful ...

Findings provide scientific insights into the contribution of small interfering RNA (siRNA) and therapeutic vaccination towards the HBV functional cure strategy DURHAM, N.C. and BEIJING, Nov. 7, 2025 ...

Celltrion announced on November 5 that it will present preclinical results for its multi-antibody new drug, CT-P72/ABP-102, at the SITC 2025 (Society ...